- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 30.57M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.33M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.32M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $2.33M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.32M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $144K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $172K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $18.15M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $19.23M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $18.28M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $19.68M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.63M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.62M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.73M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.73M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 24.92M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $6K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.55M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$15.7M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$13.44M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.36M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $445K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.11M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.1M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | −$69K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $317K |
| Revenue | Q1 2025 · Mar 31, 2024 | $248K |